Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N
Taxonomy : Homo sapiens
SNFG, Text, Oxford
taxonomy (1)
protein (1)
source (1)
structure (17)
composition (17)
disease (0)
reference (1)
site (1)
peptide (1)
- Homo sapiens (Human)
Taxonomy
- HEK293-F (CVCL_6642)
Source
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 11110
- N-Linked / Complex / Structure 11227
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 11124
- N-Linked / Complex / Structure 10835
- N-Linked / Complex / Structure 11152
- N-Linked / Complex / Structure 11154
- N-Linked / Complex / Structure 11123
- N-Linked / Complex / Structure 11253
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / Structure 9591
- N-Linked / Hybrid / Structure 11109
- N-Linked / Hybrid / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:5 dHex:2 (avg mass : 1974.8459 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
Composition
Disease
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
Reported glycosite
- NSGALTSGVHTFPAVLQSSGLY (22aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1317.2225)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1463.3655)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1520.4175)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1625.5079)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1682.5599)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1787.6503)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1828.7029)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1932.7652)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1974.8459)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 1990.8453)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 2078.9082)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / High-Mannose
(avg mass : 1235.1173)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / High-Mannose
(avg mass : 1721.5445)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Hybrid
(avg mass : 1584.4553)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Hybrid
(avg mass : 1746.5977)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
-
- N-Linked / Hybrid
(avg mass : 1891.7126)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Hybrid
(avg mass : 1891.7126)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Hybrid
(avg mass : 1746.5977)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Hybrid
(avg mass : 1584.4553)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / High-Mannose
(avg mass : 1721.5445)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / High-Mannose
(avg mass : 1235.1173)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1974.8459)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1828.7029)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1682.5599)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1520.4175)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1463.3655)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1317.2225)
